Transgenic models to study the pathogenic role of mutated and non-mutated forms of human amyloid proteins in the development of Alzheimer's disease (AD): L. Mucke1, S. Forss-Petter1, D. Goldgaber2, W. Johnson1, E. Picard3, E. Rockenstein1 and C. Abraham3. 1Depts of Neuropharmacology and Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA. 2State University of New York, Stony Brook, NY, USA. 3Depts of Medicine and Biochemistry, Boston University, Boston, MA, USA